In addition to DESI, several other techniques like nano-DESI, EASI, and LAESI
have been proposed.
Molecular information company Protea Biosciences Group (OTC BB:PRGB) disclosed on Thursday the sale of its LAESI
DP-1000 Instrument System to Purdue University for an undisclosed amount.
Molecular information company Protea Biosciences Group (OTC BB:PRGB) revealed on Wednesday the sale of its LAESI
DP-1000 Instrument System for direct molecular analysis to Princeton University.
DP-1000 directly ionizes samples in a two-step process: laser ablation followed by electrospray ionization.
15 January 2015 - US-based Purdue University has acquired US-based molecular information company Protea Biosciences Group, Inc.'s (OTCQB: PRGB) LAESI
DP-1000 Instrument System for direct molecular analysis, the company said on Thursday.
M2 PHARMA-October 15, 2014-Princeton University buys Protea's LAESI
DP-1000 Instrument System for direct molecular analysis
platform profiles the distribution of bio-molecules in tissues, plates, and for in-vivo mas spectrometry workflows.
M2 EQUITYBITES-January 15, 2015-Purdue Acquires LAESI
Technology from Protea
The alliance will utilise Protea's LAESI
direct molecular imaging platform, which will analyse its partner's 3D InSight microtissues.
M2 EQUITYBITES-October 16, 2014-Protea Biosciences Group divests LAESI
DP-1000 Instrument System to Princeton University
As part of the collaboration, the partners will use Protea's next-generation LAESI
direct molecular imaging technology to create molecular data profiles of cancer cells in tissue and biofluids to gain better insight into a cancer's origin.
Known as Laser Ablation Electrospray Ionization or "LAESI
" mass spectrometry, the technology is capable of directly identifying proteins, peptides, lipids, and metabolites found in biological samples, including tissue, blood, urine and even single cells.